Anavex Life Sciences Corp (AVXL)

[Anshu2]

Thanks for a great SUMMARY.

The only thing that will get the drug approved is “statistically significant” (p < 0.05) mean-change in Cog and/or ADL and/or CBR wrt Placebo for 30mg/50mg (pooled analysts is unconvincing).

Odds can only be supporting evidence (not core), IMO.

Of course, if we see awesome biomarker results (Ie, change compared to placebo) then the evidence becomes more convincing.

Overall, I don’t think approval chances are zero — but minimal is the best-case scenario.